341 related articles for article (PubMed ID: 11398841)
1. Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration.
Ishizawa K; Dickson DW
J Neuropathol Exp Neurol; 2001 Jun; 60(6):647-57. PubMed ID: 11398841
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Blanco R; Carmona M; Ribera R; Goutan E; Puig B; Rey MJ; Cardozo A; Viñals F; Ribalta T
Brain Pathol; 2001 Apr; 11(2):144-58. PubMed ID: 11303790
[TBL] [Abstract][Full Text] [Related]
3. Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration.
Yoshida M
Neuropathology; 2014 Dec; 34(6):555-70. PubMed ID: 25124031
[TBL] [Abstract][Full Text] [Related]
4. Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype.
Koga S; Kouri N; Walton RL; Ebbert MTW; Josephs KA; Litvan I; Graff-Radford N; Ahlskog JE; Uitti RJ; van Gerpen JA; Boeve BF; Parks A; Ross OA; Dickson DW
Acta Neuropathol; 2018 Sep; 136(3):389-404. PubMed ID: 29926172
[TBL] [Abstract][Full Text] [Related]
5. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration.
Dickson DW
J Neurol; 1999 Sep; 246 Suppl 2():II6-15. PubMed ID: 10525997
[TBL] [Abstract][Full Text] [Related]
6. Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy.
Mori H; Nishimura M; Namba Y; Oda M
Acta Neuropathol; 1994; 88(2):113-21. PubMed ID: 7985491
[TBL] [Abstract][Full Text] [Related]
7. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
Scaravilli T; Tolosa E; Ferrer I
Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
[TBL] [Abstract][Full Text] [Related]
8. Machine learning-based decision tree classifier for the diagnosis of progressive supranuclear palsy and corticobasal degeneration.
Koga S; Zhou X; Dickson DW
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):931-941. PubMed ID: 33763863
[TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
10. Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration.
Gentry EG; Henderson BW; Arrant AE; Gearing M; Feng Y; Riddle NC; Herskowitz JH
J Neurosci; 2016 Jan; 36(4):1316-23. PubMed ID: 26818518
[TBL] [Abstract][Full Text] [Related]
11. Chameleons and mimics: Progressive supranuclear palsy and corticobasal degeneration.
Mimuro M; Yoshida M
Neuropathology; 2020 Feb; 40(1):57-67. PubMed ID: 31515852
[TBL] [Abstract][Full Text] [Related]
12. Intracellular processing of aggregated tau differs between corticobasal degeneration and progressive supranuclear palsy.
Arai T; Ikeda K; Akiyama H; Tsuchiya K; Yagishita S; Takamatsu J
Neuroreport; 2001 Apr; 12(5):935-8. PubMed ID: 11303763
[TBL] [Abstract][Full Text] [Related]
13. Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration.
Wakabayashi K; Takahashi H
Neuropathology; 2004 Mar; 24(1):79-86. PubMed ID: 15068177
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
Josephs KA; Petersen RC; Knopman DS; Boeve BF; Whitwell JL; Duffy JR; Parisi JE; Dickson DW
Neurology; 2006 Jan; 66(1):41-8. PubMed ID: 16401843
[TBL] [Abstract][Full Text] [Related]
15. A proteomic study identifies different levels of light chain ferritin in corticobasal degeneration and progressive supranuclear palsy.
Ebrahim AS; Kulathingal J; Murray ME; Casey-Castanedes M; Dickson DW; Yen SH; Sevlever D
Acta Neuropathol; 2011 Dec; 122(6):727-36. PubMed ID: 22012136
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy.
Tuite PJ; Clark HB; Bergeron C; Bower M; St George-Hyslop P; Mateva V; Anderson J; Knopman DS
Arch Neurol; 2005 Sep; 62(9):1453-7. PubMed ID: 16157754
[TBL] [Abstract][Full Text] [Related]
17. Staging disease severity in movement disorder tauopathies: brain atrophy separates progressive supranuclear palsy from corticobasal degeneration.
Schofield EC; Caine D; Kril JJ; Cordato NJ; Halliday GM
Mov Disord; 2005 Jan; 20(1):34-9. PubMed ID: 15390131
[TBL] [Abstract][Full Text] [Related]
18. Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy.
Kertesz A; Munoz D
Dement Geriatr Cogn Disord; 2004; 17(4):282-6. PubMed ID: 15178937
[TBL] [Abstract][Full Text] [Related]
19. Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD.
Robinson JL; Yan N; Caswell C; Xie SX; Suh E; Van Deerlin VM; Gibbons G; Irwin DJ; Grossman M; Lee EB; Lee VM; Miller B; Trojanowski JQ
J Neuropathol Exp Neurol; 2020 Mar; 79(3):296-304. PubMed ID: 31999351
[TBL] [Abstract][Full Text] [Related]
20. [Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy].
Lass P; Sławek J; Derejko M; Dubaniewicz M
Neurol Neurochir Pol; 2003; 37 Suppl 5():263-74. PubMed ID: 15098354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
